Drug Repositioning Service Market Report 2026
Download Free Sample Buy Now
Drug Repositioning Service Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Drug Repositioning Service Market Report 2026

Global Outlook – By Type (Generic Drugs, Clinical Trial Failed Drugs), By Therapeutic Area (Oncology, Neurology, Infectious Diseases, Cardiovascular Diseases, Other Therapeutic Area), By End-User (Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations (CROs), Academic Research Institutions, Hospitals And Ambulatory Surgical Centers.) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Drug Repositioning Service Market Overview

• Drug Repositioning Service market size has reached to $34.2 billion in 2025

• Expected to grow to $45.92 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%

• Growth Driver: Surge In Rise In Healthcare Expenditures Fueling The Growth Of The Market Due To Increasing Medical Costs

• Market Trend: AI-Enabled Drug Repositioning Project

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Drug Repositioning Service Market?

Drug repositioning service involves systematically identifying new therapeutic uses for existing drugs, which allows pharmaceutical companies to maximize the value of their existing drug portfolios while minimizing the risks associated with developing entirely new compounds. Drug repositioning service leveraging existing clinical data and research, these services help streamline the drug development process, significantly reducing the time and cost required to bring effective treatments to patients.

The main types of drug repositioning service are generic drugs, and clinical trial failed drugs. Generic drugs are medications that have the same active ingredients, strength, dosage form, and therapeutic effect as brand-name drugs but are typically sold at lower prices. The various therapeutic area include oncology, neurology, infectious diseases, cardiovascular diseases, other therapeutic area. These are used by various end users such as pharmaceutical companies, biotechnology firms, contract research organizations (CROs), academic research institutions, hospitals and ambulatory surgical centers.

Drug Repositioning Service Market Global Report 2026 Market Report bar graph

What Is The Drug Repositioning Service Market Size and Share 2026?

The drug repositioning service market size has grown strongly in recent years. It will grow from $34.2 billion in 2025 to $36.19 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing pharmaceutical r&d costs, availability of extensive legacy drug data, rising number of failed clinical trials, growing demand for faster drug development cycles, early adoption of computational drug discovery.

What Is The Drug Repositioning Service Market Growth Forecast?

The drug repositioning service market size is expected to see strong growth in the next few years. It will grow to $45.92 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing demand for cost-efficient drug development, rising adoption of ai-driven discovery tools, growing focus on rare and orphan diseases, expansion of data-driven clinical research, increasing regulatory acceptance of repurposed drugs. Major trends in the forecast period include increasing use of ai-based drug repurposing platforms, rising focus on failed clinical drug re-evaluation, growing integration of real-world evidence in drug discovery, expansion of precision medicine-oriented repositioning, enhanced collaboration between pharma and cros.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Drug Repositioning Service Market Segmentation

1) By Type: Generic Drugs, Clinical Trial Failed Drugs

2) By Therapeutic Area: Oncology, Neurology, Infectious Diseases, Cardiovascular Diseases, Other Therapeutic Area

3) By End-User: Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations (CROs), Academic Research Institutions, Hospitals And Ambulatory Surgical Centers.

Subsegments:

1) By Generic Drugs: Small Molecule Drugs, Biologics, Biosimilars, Peptide-Based Drugs

2) By Clinical Trial Failed Drugs: Phase I Failed Drugs, Phase II Failed Drugs, Phase III Failed Drugs, Safety-Related Failed Drugs, Efficacy-Related Failed Drugs

What Is The Driver Of The Drug Repositioning Service Market?

The rise in healthcare expenditures is expected to propel the growth of the drug repositioning service market going forward. Healthcare expenditures refer to the total funds spent on health services, including prevention, treatment, rehabilitation, and administration. Healthcare expenditures are rising primarily due to increasing medical costs driven by technological advancements and the growing demand for healthcare services. Higher healthcare expenditure benefits drug repositioning services because increased funding allows for more clinical trials and research, accelerating the identification of new therapeutic uses for existing drugs. For instance, In May 2024, according to, Office for National Statistics, UK-based Government department, Total healthcare expenditure experienced a significant rise of 5.6% in nominal terms from 2022 to 2023. Therefore, the rise in healthcare expenditures is driving the growth of the drug repositioning service industry.

Key Players In The Global Drug Repositioning Service Market

Major companies operating in the drug repositioning service market are Recursion Pharmaceuticals Inc., Excelra, LifeArc, Cosmos Health Inc., Fios Genomics, Insilico Medicine Inc., Melior Discovery, Delta4, Acubiosys, VeriSIM Life, BioXcel Therapeutics Inc., Pharnext S.S., NuMedii, GVK Biosciences, Plex Research, Paradigm Biopharmaceuticals, BenevolentAI Limited

Global Drug Repositioning Service Market Trends and Insights

Major companies operating in the drug repositioning service market are focusing on the adoption of artificial intelligence (AI) in drug repositioning, such as computational drug repositioning systems, which systematically identify new therapeutic indications for existing drugs using AI-driven analysis of literature and biological data. A computational drug repositioning system refers to a technology-driven platform that uses artificial intelligence, machine learning, and data mining to systematically analyze existing drugs, compounds, and biological data. For instance, in November 2024, UBE and FRONTEO, Japanese-based companies, launched a co-creation project. The co-creation project offers a collaborative framework that integrates expertise from both UBE and FRONTEO to enhance drug repositioning efforts. It enables seamless interaction between dry research (data analysis) and wet research (biological testing), improving the transition from hypothesis generation to experimental validation. By leveraging FRONTEO’s AI-driven Drug Discovery AI Factory and KIBIT technology, the project systematically discovers unreported relationships between diseases and molecules.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Drug Repositioning Service Market?

In January 2024, Cosmos Health Inc., a US-based healthcare group, acquired the Cloudscreen platform for Cloudpharm P.C. for an undisclosed amount. With this acquisition, Cosmos Health Inc. aims to accelerate drug repurposing efforts by leveraging Cloudscreen’s AI platform to identify new therapeutic uses for existing drugs more efficiently. Cloudpharm P.C. is a Greece-based company that offers drug repositioning services.

Regional Insights

North America was the largest region in the drug repositioning service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Drug Repositioning Service Market?

The drug repositioning service market consists of revenues earned by entities by providing services such as target validation, pharmacovigilance support, formulation optimization, drug combination analysis, and post-marketing surveillance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Drug Repositioning Service Market Report 2026?

The drug repositioning service market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the drug repositioning service industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Drug Repositioning Service Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $36.19 billion
Revenue Forecast In 2035 $45.92 billion
Growth Rate CAGR of 5.8% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Therapeutic Area, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Recursion Pharmaceuticals Inc., Excelra, LifeArc, Cosmos Health Inc., Fios Genomics, Insilico Medicine Inc., Melior Discovery, Delta4, Acubiosys, VeriSIM Life, BioXcel Therapeutics Inc., Pharnext S.S., NuMedii, GVK Biosciences, Plex Research, Paradigm Bi
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Drug Repositioning Service Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Drug Repositioning Service Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Drug Repositioning Service Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Drug Repositioning Service Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Fintech, Blockchain, Regtech & Digital Finance

4.2. Major Trends

4.2.1 Increasing Use Of Ai-Based Drug Repurposing Platforms

4.2.2 Rising Focus On Failed Clinical Drug Re-Evaluation

4.2.3 Growing Integration Of Real-World Evidence In Drug Discovery

4.2.4 Expansion Of Precision Medicine-Oriented Repositioning

4.2.5 Enhanced Collaboration Between Pharma And Cros

5. Drug Repositioning Service Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies

5.2 Biotechnology Firms

5.3 Contract Research Organizations

5.4 Academic Research Institutions

5.5 Hospitals And Ambulatory Surgical Centers

6. Drug Repositioning Service Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Drug Repositioning Service Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Drug Repositioning Service PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Drug Repositioning Service Market Size, Comparisons And Growth Rate Analysis

7.3. Global Drug Repositioning Service Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Drug Repositioning Service Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Drug Repositioning Service Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Drug Repositioning Service Market Segmentation

9.1. Global Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Generic Drugs, Clinical Trial Failed Drugs

9.2. Global Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Neurology, Infectious Diseases, Cardiovascular Diseases, Other Therapeutic Area

9.3. Global Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations (CROs), Academic Research Institutions, Hospitals And Ambulatory Surgical Centers

9.4. Global Drug Repositioning Service Market, Sub-Segmentation Of Generic Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Small Molecule Drugs, Biologics, Biosimilars, Peptide-Based Drugs

9.5. Global Drug Repositioning Service Market, Sub-Segmentation Of Clinical Trial Failed Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Phase I Failed Drugs, Phase II Failed Drugs, Phase III Failed Drugs, Safety-Related Failed Drugs, Efficacy-Related Failed Drugs

10. Drug Repositioning Service Market Regional And Country Analysis

10.1. Global Drug Repositioning Service Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Drug Repositioning Service Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Drug Repositioning Service Market

11.1. Asia-Pacific Drug Repositioning Service Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Drug Repositioning Service Market

12.1. China Drug Repositioning Service Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Drug Repositioning Service Market

13.1. India Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Drug Repositioning Service Market

14.1. Japan Drug Repositioning Service Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Drug Repositioning Service Market

15.1. Australia Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Drug Repositioning Service Market

16.1. Indonesia Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Drug Repositioning Service Market

17.1. South Korea Drug Repositioning Service Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Drug Repositioning Service Market

18.1. Taiwan Drug Repositioning Service Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Drug Repositioning Service Market

19.1. South East Asia Drug Repositioning Service Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Drug Repositioning Service Market

20.1. Western Europe Drug Repositioning Service Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Drug Repositioning Service Market

21.1. UK Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Drug Repositioning Service Market

22.1. Germany Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Drug Repositioning Service Market

23.1. France Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Drug Repositioning Service Market

24.1. Italy Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Drug Repositioning Service Market

25.1. Spain Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Drug Repositioning Service Market

26.1. Eastern Europe Drug Repositioning Service Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Drug Repositioning Service Market

27.1. Russia Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Drug Repositioning Service Market

28.1. North America Drug Repositioning Service Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Drug Repositioning Service Market

29.1. USA Drug Repositioning Service Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Drug Repositioning Service Market

30.1. Canada Drug Repositioning Service Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Drug Repositioning Service Market

31.1. South America Drug Repositioning Service Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Drug Repositioning Service Market

32.1. Brazil Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Drug Repositioning Service Market

33.1. Middle East Drug Repositioning Service Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Drug Repositioning Service Market

34.1. Africa Drug Repositioning Service Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Drug Repositioning Service Market Regulatory and Investment Landscape

36. Drug Repositioning Service Market Competitive Landscape And Company Profiles

36.1. Drug Repositioning Service Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Drug Repositioning Service Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Drug Repositioning Service Market Company Profiles

36.3.1. Recursion Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Excelra Overview, Products and Services, Strategy and Financial Analysis

36.3.3. LifeArc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Cosmos Health Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Fios Genomics Overview, Products and Services, Strategy and Financial Analysis

37. Drug Repositioning Service Market Other Major And Innovative Companies

Insilico Medicine Inc., Melior Discovery, Delta4, Acubiosys, VeriSIM Life, BioXcel Therapeutics Inc., Pharnext S.S., NuMedii, GVK Biosciences, Plex Research, Paradigm Biopharmaceuticals, BenevolentAI Limited

38. Global Drug Repositioning Service Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Drug Repositioning Service Market

40. Drug Repositioning Service Market High Potential Countries, Segments and Strategies

40.1 Drug Repositioning Service Market In 2030 - Countries Offering Most New Opportunities

40.2 Drug Repositioning Service Market In 2030 - Segments Offering Most New Opportunities

40.3 Drug Repositioning Service Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Drug Repositioning Service Market, Overview Of Key Products - Product Examples
  • Table 2: Global Drug Repositioning Service Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Drug Repositioning Service Market, Supply Chain Analysis
  • Table 4: Global Drug Repositioning Service Market, Major Raw Material Providers
  • Table 5: Global Drug Repositioning Service Market, Major Resource Providers
  • Table 6: Global Drug Repositioning Service Market, Major Manufacturers (Suppliers)
  • Table 7: Global Drug Repositioning Service Market, Major Distributors And Channel Partners
  • Table 8: Global Drug Repositioning Service Market, Key Technologies & Future Trends
  • Table 9: Global Drug Repositioning Service Market, Major Trends
  • Table 10: Global Drug Repositioning Service Market, Major End Users
  • Table 11: Global Drug Repositioning Service Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Drug Repositioning Service Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Drug Repositioning Service Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Drug Repositioning Service Market - TAM, US$ Billion, 2025
  • Table 15: Global Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Drug Repositioning Service Market, Sub-Segmentation Of Generic Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Drug Repositioning Service Market, Sub-Segmentation Of Clinical Trial Failed Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Drug Repositioning Service Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Drug Repositioning Service Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Drug Repositioning Service Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Drug Repositioning Service Market - Company Scoring Matrix
  • Table 96: Recursion Pharmaceuticals Inc. Financial Performance
  • Table 97: Excelra Financial Performance
  • Table 98: LifeArc Financial Performance
  • Table 99: Cosmos Health Inc. Financial Performance
  • Table 100: Fios Genomics Financial Performance
  • Table 101: Global Drug Repositioning Service Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Drug Repositioning Service Market, Competitive Dashboard
  • Table 103: Global Drug Repositioning Service Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Drug Repositioning Service Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 105: Global, Drug Repositioning Service Market Size Gain ($ Billion), Segmentation By Therapeutic Area, 2025 – 2030
  • Table 106: Global, Drug Repositioning Service Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

    Figure 1: Global Drug Repositioning Service Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Drug Repositioning Service Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Drug Repositioning Service Market, Supply Chain Analysis
  • Figure 4: Global Drug Repositioning Service Market, Major Raw Material Providers
  • Figure 5: Global Drug Repositioning Service Market, Major Resource Providers
  • Figure 6: Global Drug Repositioning Service Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Drug Repositioning Service Market, Major Distributors And Channel Partners
  • Figure 8: Global Drug Repositioning Service Market, Key Technologies & Future Trends
  • Figure 9: Global Drug Repositioning Service Market, Major Trends
  • Figure 10: Global Drug Repositioning Service Market, Major End Users
  • Figure 11: Global Drug Repositioning Service Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Drug Repositioning Service Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Drug Repositioning Service Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Drug Repositioning Service Market - TAM, US$ Billion, 2025
  • Figure 15: Global Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Drug Repositioning Service Market, Sub-Segmentation Of Generic Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Drug Repositioning Service Market, Sub-Segmentation Of Clinical Trial Failed Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Drug Repositioning Service Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Drug Repositioning Service Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Drug Repositioning Service Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Drug Repositioning Service Market - Company Scoring Matrix
  • Figure 96: Recursion Pharmaceuticals Inc. Financial Performance
  • Figure 97: Excelra Financial Performance
  • Figure 98: LifeArc Financial Performance
  • Figure 99: Cosmos Health Inc. Financial Performance
  • Figure 100: Fios Genomics Financial Performance
  • Figure 101: Global Drug Repositioning Service Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Drug Repositioning Service Market, Competitive Dashboard
  • Figure 103: Global Drug Repositioning Service Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Drug Repositioning Service Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 105: Global, Drug Repositioning Service Market Size Gain ($ Billion), Segmentation By Therapeutic Area, 2025 – 2030
  • Figure 106: Global, Drug Repositioning Service Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Drug Discovery Services Market Report 2026 - Global Outlook – By Type (Chemistry Services, Biology Services), By Process (Target Selection, Target Validation, Hit-To-Lead identification, Lead Optimization, Candidate Vali...

Controlled Substance Market Report 2026 - Global Outlook – By Drug (Opioids, Stimulant, Depressants, Cannabinoids), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (Pain Mana...

Behavioral Rehabilitation Market Report 2026 - Global Outlook – By Treatment Method (Counseling, Medication, Support Services, Other Treatment Methods), By Application (Anxiety Disorders, Mood Disorders, Substance Abuse ...

Drug Device Combination Market Report 2026 - Global Outlook – By Product (Auto-Injector, Microneedle Patch, Digital Pill, Smart Inhaler, Drug Delivery Hydrogels, Drug-Eluting Lens, Other Products), By Distribution Channe...

Pharmaceutical Logistics Market Report 2026 - Global Outlook – By Type (Cold Chain Logistics, Non-Cold Chain Logistics), By Component (Storage, Transportation, Monitoring Components), By Procedure (Picking, Storage, Retr...

Medication Management System Market Report 2026 - Global Outlook – By Product Type (Computerized Physician Order Entry, Clinical Decision Support System Solutions, Electronic Medication Administration Record, Inventory M...

Pharmacies and Drug Stores Market Report 2026 - Global Outlook – By Drug Type (Prescription Drugs, Over-The-Counter (OTC) Drugs), By Pharmacy Type (Community Pharmacy, Hospital Pharmacy, Clinical Pharmacy, Compounding Ph...

Pharmacy Management System Market Report 2026 - Global Outlook – By Component (Software, Hardware, Services), By Deployment (Web Based, On Premise), By End User (Inpatient Pharmacies, Outpatient Pharmacies) - Market Size...

Frequently Asked Questions

The Drug Repositioning Service market was valued at $34.2 billion in 2025, increased to $36.19 billion in 2026, and is projected to reach $45.92 billion by 2030.

The global Drug Repositioning Service market is expected to grow at a CAGR of 6.1% from 2026 to 2035 to reach $45.92 billion by 2035.

Some Key Players in the Drug Repositioning Service market Include, Recursion Pharmaceuticals Inc., Excelra, LifeArc, Cosmos Health Inc., Fios Genomics, Insilico Medicine Inc., Melior Discovery, Delta4, Acubiosys, VeriSIM Life, BioXcel Therapeutics Inc., Pharnext S.S., NuMedii, GVK Biosciences, Plex Research, Paradigm Biopharmaceuticals, BenevolentAI Limited .

Major trend in this market includes: AI-Enabled Drug Repositioning Project. For further insights on this market. request a sample here

North America was the largest region in the drug repositioning service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug repositioning service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us